By increasing feelings of fullness, these medications help patients reduce calorie intake and manage their weight more effectively
The FDA approved saxagliptin, linagliptin, and alogliptin, and the European Union and Japan approved vildagliptin, anagliptin, teneligliptin, trelagliptin, and omarigliptin
Critical clarification: These results come from clinical trials of FDA-approved branded medications conducted under controlled conditions with specific patient populations
Unidentified Speaker Person No, this is under your investigation investigations
The elderly, and those affected by chronic disease, especially the respiratory and immuno- compromised, seem to be most vulnerable to COVID-19 infection and its complications [2]
Ask Now At AlphaMD, we're here to help